Heart drug put to the test in african american patients
NCT ID NCT05168787
First seen Mar 29, 2026 · Last updated Apr 25, 2026 · Updated 2 times
Summary
This study looked at how well the drug sacubitril/valsartan works in African American patients with heart failure. Over 6,500 participants were followed for at least three months. The goal was to see if the drug reduces deaths and hospital stays, since earlier research suggested it might work differently in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center Pharmacy
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.